» Articles » PMID: 16703566

Macrophages Require Distinct Arginine Catabolism and Transport Systems for Proliferation and for Activation

Overview
Journal Eur J Immunol
Date 2006 May 17
PMID 16703566
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

In murine macrophages, as a result of arginine catabolism during activation, citruline is produced under the effect of IFN-gamma and LPS, and ornithine and polyamines by IL-4 and IL-10. For proliferation, arginine is required from the extracellular medium and is used for protein synthesis. During activation, most arginine (>95% in 6 h) was metabolized, while under proliferation only half was incorporated into proteins. Under basal conditions, this amino acid was preferentially transported by y(+)L activity. During activation, arginine transport increased drastically (4-5-fold) through y(+) cationic amino acid transporter (CAT) activity. By contrast, M-CSF induced only a modest increase in uptake (0.5-fold). The increase in arginine transport during activation, but not proliferation, was mediated by the SLC7A2/Cat2 gene. SLC7A1/Cat1 is constitutively expressed, and is not modified by proliferating or activating agents. M-CSF-dependent proliferation was not affected in the macrophages of SLC7A2 knockout mice; however, these cells showed a drastic reduction in the production of citruline or ornithine and polyamines during activation. The data show that a large increase in a specific transport system (CAT2) is necessary for activation-induced arginine metabolism, while arginine is in excess for the requirements of proliferation and a modest increase in transport occurs.

Citing Articles

The arginine/ornithine binding protein ArgT plays an essential role in / to prevent intracellular killing and contribute to chronic persistence in the host.

Mallik S, Joshi K, Radhakrishnan G Virulence. 2024; 15(1):2421983.

PMID: 39463062 PMC: 11540086. DOI: 10.1080/21505594.2024.2421983.


Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.

Yang L, Chu Z, Liu M, Zou Q, Li J, Liu Q J Hematol Oncol. 2023; 16(1):59.

PMID: 37277776 PMC: 10240810. DOI: 10.1186/s13045-023-01453-1.


Tumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization.

Chen Y, Lowery A, Lin S, Walker A, Chen K Cancer Cell Int. 2022; 22(1):351.

PMID: 36376929 PMC: 9664648. DOI: 10.1186/s12935-022-02769-7.


You are what you eat: How to best fuel your immune system.

Hellmich C, Wojtowicz E Front Immunol. 2022; 13:1003006.

PMID: 36211413 PMC: 9533172. DOI: 10.3389/fimmu.2022.1003006.


GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.

Missiaen R, Anderson N, Kim L, Nance B, Burrows M, Skuli N Cell Metab. 2022; 34(8):1151-1167.e7.

PMID: 35839757 PMC: 9357184. DOI: 10.1016/j.cmet.2022.06.010.